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Studies on the possible association between blood
pressure and blood lead have reached divergent con-
clusions. In a previous meta-analysis, a doubling of the
blood lead concentration was associated with a 1.0/0.6
mm Hg increase in systolic and diastolic blood pressure
(BP). This meta-analysis updates the analysis originally
performed in 1994. Articles on the association between
BP and blood lead were identified from computer
searches from January 1980 to February 2001 using the
Medical Literature Analysis and Retrieval System. Of the
studies reviewed, 31 provided sufficient details to be
considered. The meta-analysis included 58518 subjects
recruited from the general population in 19 surveys and
from occupationally exposed groups in 12 studies. In all
but four studies, the results were adjusted for age, and
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Introduction
Environmental and occupational lead exposure is a
common public health concern. Lead accumulates
in the human body during life and has been impli-
cated in the pathogenesis of renal dysfunction1 and
hypertension.2–4 Several plausible pathophysiologic
mechanisms for the involvement of lead in hyper-
tension have been proposed, but the reports dealing
with a positive and causal association between lead
exposure and blood pressure elevation are not uni-
versally accepted. A meta-analysis of the available
human studies in 1994 suggested that a two-fold
increase in the blood lead concentration would be
associated with a 1.0 mm Hg increase in systolic
blood pressure (95% confidence interval (CI): +0.4
to +1.6 mm Hg) and a 0.6 mm Hg increase in dias-
tolic blood pressure (95% CI: +0.2 to +1.0 mm Hg).5
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most studies took into account additional confounding
factors such as body mass index and the use of alcohol
and medication. Weighted joint P-values were calcu-
lated using Stouffer’s procedure. The association
between BP and blood lead was similar in both men and
women. In the combined studies, a two-fold increase in
blood lead concentration was associated with a 1.0
mm Hg rise in the systolic pressure (95% CI0.5 to1.4
mm Hg; P  0.001) and with a 0.6 mm Hg increase in
the diastolic pressure (95% CI 0.4 to 0.8 mm Hg; P 
0.001). On balance, this meta-analysis suggests that
there can only be a weak association between BP and
blood lead.
Journal of Human Hypertension (2002) 16, 123–131. DOI:
10.1038/sj/jhh/1001300
This weak positive relationship was attributed to
confounding rather than to causation.
In view of continuing controversy6,7 about the
possible causal association between blood pressure
and lead exposure, and the decrease of the blood
lead concentrations in most western populations,6
we updated our previous meta-analysis5 to deter-
mine whether all the available data up to February
2001 support a positive association and how strong
such a relationship between blood pressure and lead
may be.
Methods
General design
The first step of this meta-analysis consisted of
identification of relevant studies for inclusion. In
accordance with current guidelines,8,9 criteria
determining the eligibility of studies for inclusion
were established before the actual statistical analysis
was undertaken. The effect of lead exposure on
blood pressure, and its standard error, were then
identified for each group of subjects included in
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individual studies. As a next step in the analysis, the
estimates of the association size from the individual
studies were expressed on a common scale in order
to make the calculation of a combined association
size possible. However, before pooling was under-
taken whether the studies could reasonably be
described as sharing a common association size, was
first determined8,9 by a statistical test of homogen-
eity. A combined association size and corresponding
P-values were then computed, combining the evi-
dence that from all studies both with and without
weighting by the size of the groups included in the
analysis. Finally, a sensitivity analysis was perfor-
med to ensure that the results from the combined
data set were not critically dependent on only one
or a few studies.
Data collection
Articles on the association between blood pressure
and lead exposure were identified (1) from computer
searches of the English, French and German litera-
ture from January 1980 to February 2001, using the
Medical Literature Analysis and Retrieval System
(MEDLARS), (2) from existing compilations of the
literature,4,10 and (3) via presentations at inter-
national meetings. Studies under the 50 subjects
were excluded because they might not have had the
power to detect a positive relation between blood
pressure and blood lead. We excluded studies in
children below the age of 10 years, because blood
pressure in children is highly variable and correlates
highly with height. Studies were further eligible for
inclusion if both blood pressure and blood lead had
been measured and presented with sufficient detail
to estimate or calculate the size of the association.
If a group published two or more papers describing
the same study population, only the publication
providing the most detailed information was
included in the analysis. When possible, preference
was given to blood pressure results adjusted for age,
body mass index and additional factors of proven
importance. Whenever possible, men, women,
whites, and blacks were analysed as separate
groups.
Estimation of the association size
The association size was estimated for each group
of subjects as the blood pressure change that would
be associated with a doubling of the blood lead con-
centration. For reports in which blood lead was
expressed on a linear scale, the association size was
calculated, assuming a two-fold increase of the mean
blood lead concentration. For studies in which the
association size was expressed on a logarithmic
scale, the change in blood pressure associated with
a doubling of the blood lead concentration was cal-
culated by multiplying the regression coefficient by
0.30, if common logarithms had been used and by
0.69 for natural logarithms.
The standard error of the blood pressure differ-
ence associated with a given change in the blood
lead concentration was not reported in all studies.
In these instances, the standard error was estimated
from the published association size and the test stat-
istic corresponding with the reported P-value. If the
parameters of a non-significant blood pressure effect
were not reported, the authors of the paper were
contacted in order to avoid bias resulting from the
exclusion of non-significant studies, an important
problem in any meta-analysis.11 If no additional
information was made available, according to the
suggestion of Needleman and Gatsonis,12 the non-
significant effects were assumed to be zero and the
non-significant P-values to be 0.50. Summary stat-
istics were then calculated both with and without
the studies for which these assumptions had to be
made.
Statistical analysis
Statistical analyses were performed with the SAS
software version 6.12 (The SAS Institute, Cary, NC,
USA). Joint P-values were calculated by two differ-
ent techniques, ie by Stouffer’s method, as modified
by Mosteller and Bush, and by Fisher’s approach.8
In Fisher’s procedure, the logarithm of the product
of the individual P-values was multiplied by −2. The
resulting quantity follows a chi-square distribution
with 2k degrees of freedom, where k refers to the
number of combined groups. Fisher’s procedure was
not weighted, because weighting may produce com-
putational instability.8 Stouffer’s procedure
involved transforming each P-value to its corre-
sponding normal score and then averaging these z-
scores, using degrees of freedom (number of subjects
−1) as weights. The weighted z-score average was
employed to construct one-sided 95% CI for the
combined association size. As a test of homogeneity,
the z-scores of the individual studies were ranked
and plotted to investigate whether they were on a
straight line.
Results
Selection of studies
Of the studies reviewed3,4,6,13–88 22 reports were
excluded. Two studies reported only on young chil-
dren (10 years),25,37 two studies were case
reports,45,48 one66 recruited less than 50 persons, in
one54 owing to missing information the analysis was
performed in less than 50 subjects, five estimated
exposure from other measurements than the blood
lead concentration,30,77,78,81,88 and 11 did not provide
enough information to compute the association
size.17,19,22,26,27,36,39,62,63,67,86
Characteristics of the selected studies
The 31 studies included in the meta-analysis are
listed in chronological order in Table 1. Of these, 19
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Author No. Pop Men HT Age SBP DBP Lead (mol/L) QC Scale Info
(%) (years)
Pocock et al59,71 7379 GP 100 Y 49 (40–59) 145 82 0.73 (0.10–3.20)Ae BP, L Log S, C, R
Kromhout et al46,47 152 GP 100 Y 67 (57–76) 154 92 0.88 (0.52–1.35)Ac BP, L Lin 0
Orssaud et al50,51,56 431 WC 100 Y 41 (24–55) 131 75 0.88 (0.43–2.41)Ae BP Lin S, C, R
Weiss et al84,85 89 WC 100 Y 47 (30–64) 122 83 1.18 (0.9–1.4)Mx BP Lin (D) 0
de Kort et al28,29 105 BC 100 N 40 (25–80) 136 83 1.41 (0.21–4.02)Ae BP Lin S, C, R
Lockett and Arbuckle14 116 BC 100 Y 32 (?–?) 119 80 1.81 (0.72–4.61)Ae ND Lin (G) 0
Parkinson et al57 428 BC 100 Y 36 (18–60) 127 80 1.35 (0.29–2.39)Ac BP Lin 0
Rabinowitz et al61 3851 GP 0 Y 28 (18–38) 121 76 0.34 (0.18–0.49)Ac BP0 Ln S, R.
Elwood et al (1)34,35 1136 GP 100 Y 56 (49–65) 146 87 0.61 (0.29–1.26)Gc BP Log 0
Elwood et al (2)32,33 1721 GP 50 Y 41 (18–64) 127 78 0.49 (0.22–1.12)Gc BP Log 0
Gartside et al (3)15,38,42,58,69 6289 GP 53 Y 30 (10–74) 127 80 0.65 (0.10–4.63)Ge BP, L Log S, C, R
Neri et al (4)55 288 BC 100 ? ? (?–?) ? ? 2.18 (0.29–3.14)Ae ND Lin S
Neri et al (5)55 2193 GP ? Y 45 (25–65) ? ? 1.13 (0.00–2.27)Me ND Lin NA
Grandjean et al (6)40,41 1050 GP 48 Y 40 (40–40) ? ? 0.56 (0.19–2.90)Ae BP, L Ln 0
Reimer and Tittelbach63 58 BC 100 ? 32 (?–?) 134 81 1.93 (0.62–3.39)Ac ND Lin (G) 0
Apostoli et al13 525 GP 48 Y 45 (21–60) 132 84 0.63 (0.10–1.36)Ae BP Lin S, C, R
Morris et al52 251 GP 58 Y ? (23–79) ? ? 0.36 (0.24–1.88)Ae BP Ln NA
Sharp et al72,73,74 249 WC 100 N 43 (31–65) 128 83 0.32 (0.10–0.72)Pe BP, L Ln 0
Staessen et al (7)78 531 WC 75 Y 48 (37–58) 126 78 0.55 (0.20–1.70)Ge BP, L Log 0
Møller et al (8)53 439 GP 100 Y 40 (40–40) ? ? 0.66 (0.24–2.90)Ae BP, L Ln 0
Hense et al43 3364 GP 51 Y 48 (28–67) 129 80 0.38 (0.06–1.79)Ae BP, L Lin S, C, R
Maheswaran et al14 809 BC 100 Y 43 (20–65) 129 84 1.53 (0.00–4.73)Ae BP Lin S, C, R
Menditto et al49 1319 GP 100 Y 63 (55–75) 140 84 0.54 (0.30–1.19)K BP, L Lin NA
Proctor et al (9)44,60 798 GP 100 Y 66 (43–93) 134 80 0.27 (0.02–1.69)Pe BP, L Ln 0
Staessen et al (10)6,32,80 728 GP 49.3 Y 46 (20–82) 130 77 0.44 (0.08–3.50)Ge BP, L Log 0
Sokas et al75,a 186 BC 99 Y 43 (18–79) 130 85 0.36 (0.10–1.45)Pe BP, L Lin NA
Bost et al20 5326 GP 48 Y 48 (16–?) 135 75 3.08 (?–?)G BP Log R
Chu et al24 2800 GP 53 Y 44 (15–85) 123 78 0.31 (0.02–3.33)Ae BP, L Ln 0
Rothenberg et al64,65 1627 GP 0 Y 27 (?–?) 110 59 0.11 (?–?)G BP, L Ln 0
Schwartz et al68 543 BC 100 Y 58 (41–73) 128 77 0.22 (0.05–0.97)Ae BP, L Lin 0
Den Hond et al (11)31 13781 GP 53.2 Y 48 (20–90) 125 73 0.15 (0.03–2.70)Ge BP, L Log S
No.: Number of persons in whom relevant data were available.
Pop.: Study population: GP, sample from general population; BC, blue collar workers; WC, white collar employees.
Men.: Percentage of men.
HT.: Indicates whether the sample included (Y = yes) or did not include (N = no) hypertensive patients.
Age.: Mean age or midpoint of age span (range or approximate range given between parentheses).
SBP, DBP: Mean systolic and diastolic blood pressures.
Lead: Measure of central tendency: A = arithmetic mean, G = geometric mean, P = P50 (median), M = midpoint of range. The spread
of blood lead is given between parentheses: e = extremes, c = P5−P95 interval, P10−P90 interval, or interval equal to 4 times the standard
deviation, x = approximate limits of distribution.
QC: Quality control. BP indicates that the blood pressure measurements were well standardized; L stands for the explicit mention in
the published papers of a quality control programme for the blood lead determinations; BP0 means that the blood pressure readings
were not standardized and ND that the published articles provided no details on the standardization of the blood pressure measurements
nor on the quality control of the lead determinations.
Scale: The scale on which blood lead was expressed to compute the association size: lin = linear; log = common logarithm and in =
natural logarithm. G indicates that the blood pressure was compared between groups with low and high exposure to lead and D that
groups were contrasted in a regression model with use of dummy variables.
Info. Information provided by the authors: 0 = no information requested; NA = information requested, but no longer available; S =
descriptive statistics; C = single (unadjusted) correlations.
R = multiple linear regression equations. Where available, the information provided by the authors was used rather than the often
incomplete published data.
(1) Caerphilly Study (2) Welsh Heart Program, (3) NHANES II (National Health and Nutrition Examination Survey), (4) foundry workers,
(5) Canadian Health Survey, (6) Glostrup Population Study, cross-sectional analysis (1976), (7) London Civil Servants, (8) Glostrup
Population Study, longitudinal analysis (1976–1987), (9) Normative aging study, (10) PheeCad (Public Health and Environmental
Exposure to Cadmium) Study, (11) NHANES III Survey.
aBecause of missing information, only the effect in whites is included.
recruited participants from the general population,
four included employees with clerical jobs and eight
blue collar workers such as iron workers (Table 1).
In 24 cross-sectional studies, and four prospective
studies, the possible influence of lead exposure was
investigated by regressing blood pressure on blood
lead. In three studies13,16,63 the blood pressure was
measured in exposed and control groups with dif-
Journal of Human Hypertension
fering blood lead levels. The longitudinal Boston84,85
and Glostrup53 studies applied autoregression to
investigate the correlation between lead at baseline
and blood pressure during follow-up.
The blood lead concentration was expressed on a
linear scale in 15 studies and on a logarithmic scale
in 16 (Table 1). Only four studies,13,16,34,63 calculated
the association between blood pressure and blood
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lead without any adjustment for possible confoun-
ders and one49 reported only the unadjusted associ-
ation size with sufficient detail to be included in the
analysis. In all but six reports,13,16,34,40,49,63 the
results were adjusted for age. However, in one of
these six reports all subjects were of the same age.40
Body mass index or body weight was entered into
the multivariate models of 22 studies.6,13,14,24,31,
38,40,43,46,53,55–57,59–61,65,68,72,75,79,84 Most studies also
considered additional confounding variables, such
as smoking,13,14,24,31,38,40,53,57,60,61,68,79,84 alcohol con-
sumption,6,13,14,24,31,38,40,43,53,56,57,60,71,79,85 intake of
caffeine,65,72 milk, dietary calcium intake or serum
calcium,6,24,52,60,79 serum zinc,55 exposure to cad-
mium,28 the blood haemoglobin concentration40,55,75
or haematocrit,6,31,43,61 physical activity or fit-
ness,40,53,60 socio-economic status38,57,71 and meno-
pausal status.6
The 31 studies listed in Table 1 included 48 differ-
ent groups of subjects. Of these groups, 32 consisted
only of men or almost exclusively of men (99%),75
15 only of women, and one55 comprised both men
and women. The combined estimates involved
58518 subjects for systolic blood pressure and
58491 subjects for diastolic blood pressure. The
association sizes for each of the groups involved in
the meta-analysis were obtained for systolic (Figure
1) and diastolic (Figure 2) blood pressure.
Summary statistics
The z-scores for all the groups included in the meta-
analysis represented a continuum with no evidence
for a bimodal or other distribution. Thus, the
hypothesis of homogeneity was not rejected.
Table 2 shows the combined P-values obtained via
Fisher’s method and via Stouffer’s approach for both
sexes combined and for men and women separately.
The results in men and women were not signifi-
cantly different with P-values of 0.4 and 0.9 for sys-
tolic and diastolic blood pressure, respectively
(Table 2). For all groups and both sexes combined,
a two-fold increase of the blood lead concentration
was associated with a 1.0 mm Hg increase in systolic
pressure (95% CI: +0.5 to +1.4 mm Hg; P  0.001),
and with a 0.6 mm Hg rise in the diastolic pressure
(CI: +0.4 to +0.8 mm Hg; P  0.001).
In four studies31,38,65,74 the association size was
reported separately for whites (n = 15911) and non-
whites (n = 6035). For white subjects the association
was 0.4 mm Hg (CI: −0.7 to +1.5 mm Hg; P = 0.26)
for systolic pressure and 0.2 mm Hg (+0.1 to +0.3
mm Hg; P  0.001) for diastolic pressure. For non-
whites the corresponding estimates were 1.4 mm Hg
(CI: +0.9 to +1.9 mm Hg; P  0.001) and 0.7 mm Hg
(+0.5 to +0.9 mm Hg; P = 0.04) for systolic and dias-
tolic blood pressure, respectively.
In a further step of the analysis, subgroups were
excluded for whom the association size was
reported as non-significant, but for whom details of
the statistical parameters were not available. This
excluded two studies on systolic pressure52,55 and
two on diastolic pressure52,61 in women. In this
analysis doubling of the blood lead concentration
was associated with an increase in systolic pressure
by 1.0 mm Hg (CI: +0.5 to +1.5 mm Hg; P  0.001),
and with a rise in the diastolic pressure by +0.7
mm Hg (CI: +0.5 to +0.9 mm Hg; P  0.001).
Sensitivity analysis
The sensitivity of the findings was examined by
removing one study at the time from the analysis
and recalculating the joint P-values, using Stouffer’s
method. For systolic pressure, the combined P-value
dropped to 0.002 when a study in women at the end
of pregnancy61 was excluded. The 95% confidence
limits of the association size (+1.0 mm Hg) for sys-
tolic pressure ranged from +0.4 to +1.6 mm Hg.
In the groups (n = 31) where the relationship
between blood pressure and blood lead was studied
on a logarithmic scale (n = 49320), the association
size averaged +0.8 mm Hg (CI: +0.4 to +1.2 mm Hg;
P = 0.001) for systolic pressure and +0.5 mm Hg (CI:
+0.3 to +0.7 mm Hg; P = 0.005) for diastolic pressure.
In the 17 other groups (n = 9198), in which the
association was studied on a linear scale, these esti-
mates were +1.9 mm Hg (+0.7 to + 3.2 mm Hg; P =
0.006) and +1.4 mm Hg (+0.5 to +2.2 mm Hg; P =
0.003), respectively.
Across the 48 groups there was no significant
relationship between the association size and the
mean blood lead concentration, the weighted corre-
lation coefficient was 0.27 (P = 0.07) for systolic
pressure and 0.17 (P = 0.23) for diastolic pressure.
Discussion
The present meta-analysis of 31 studies, with a com-
bined total of 58518 subjects, assessed the associ-
ation between blood pressure and blood lead. Our
results showed that a doubling of the blood lead
concentration is associated with an increase of 1.0
mm Hg in systolic blood pressure and a 0.6 mm Hg
rise in diastolic pressure. These findings are in
agreement with our previous meta-analysis pub-
lished in 1994 which included 23 studies in
33141 subjects.5
These overall results must be cautiously inter-
preted. It was assumed in the analysis that all stud-
ies provided an estimate of a common association
size. Although the evaluation of the homogeneity
across studies did not refute this hypothesis, the
various studies considered different factors as poss-
ible confounders. However, with the exception of
age, there is no general agreement on the covariates
that should be taken into account in estimating the
relationship between blood pressure and blood lead.
This may possibly have affected the estimate of the
combined association size. A meta-analysis perfor-
med by Schwartz J et al70 in 1995 included 15 stud-
ies and showed that a doubling of the blood lead
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Figure 1 Change in the systolic pressure (association size in mm Hg with 95% confidence interval) associated with a doubling of the
blood lead concentration. Circles represent individual groups and squares the combined association sizes. Open circles denote groups
for whom a non-significant systolic52,55 association size was assumed to be zero. C: Caerphilly Study; HP: Welsh Heart Program; W:
Whites; B: Blacks; NI: Non-immigrants; I: Immigrants; FW: Foundry Workers; CS: Civil Servants; P: PheeCad (Public Health and Environ-
mental Exposure to Cadmium) Study.
concentration was associated with a significant
increase of 1.25 mm Hg in systolic blood pressure,
which was 0.25 mm Hg higher than in the present
analysis.
The change in blood pressure associated with a
doubling of the blood lead concentration was calcu-
lated for all groups included in the present meta-
analysis. A two-fold increase in blood lead was
selected since it was less than or equal to the range
of the non-industrial population means of blood
lead for the studies included here. Moreover, within
the groups included in each study, more than a
Journal of Human Hypertension
doubling of blood lead concentration was observed
as evidenced by the measures of central tendency
and the ranges of the blood lead concentrations.
According to the Science Citation Index, studies
considered as supportive of a hypothesis are cited
almost six times more frequently than negative stud-
ies.89 To exclude bias the present analysis estimated
the overall blood pressure effects both with and
without the studies,52,55,61 for which the non-
significant associations had been assumed to be
zero. In addition, for 13 studies detailed information
was made available by the authors.
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Figure 2 Change in the diastolic pressure (association size in mm Hg with 95% confidence interval) associated with a doubling of the
blood lead concentration. Open circles denote groups for whom a non-significant diastolic52,61 association size was assumed to be zero.
For further details see caption to Figure 1.
It is noteworthy that some large studies, which
supported a positive relationship between blood
pressure and blood lead, based their conclusions on
a single blood pressure reading.42,58 Some reports
based on the NHANES II Study (1976–1980) showed
a relationship between blood pressure and blood
lead concentration that was particularly strong
among white middle-aged men.69 However, the
quality of the blood pressure measurements was
questionable.38 The NHANES III investigators
(1988–1994) recognised this problem and measured
seated blood pressure three times.31 Twenty-four
hour ambulatory blood pressure recordings are
characterised by high reproducibility, are not sub-
ject to digit preference or observer bias and mini-
mise the transient rise of a person’s blood pressure
in response to the observer, the so-called white-coat
effect.90 Only one study6 used this new technique of
blood pressure measurement but did not support the
hypothesis of a consistent positive relationship
between blood pressure and blood lead concen-
tration.
Successful conduct of a meta-analysis is predi-
cated upon there being similar effects in different
sub-groups. Pooling data from many different stud-
ies could mask impacts in susceptible populations
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No. Chi-square Z-score Association size
Both sexesa
All studies SBP 58518 210 (0.001) 6.6 (0.001) +1.0 (+0.5 to +1.4)
DBP 58491 229 (0.001) 5.3 (0.001) +0.6 (+0.4 to +0.8)
Menb
All studies SBP 32268 210 (0.001) 6.6 (0.001) +1.2 (+0.6 to +1.7)
DBP 32263 143 (0.001) 5.5 (0.001) +0.6 (+0.4 to +0.8)
Women
All studies SBP 24057 63 (=0.003) 2.7 (=0.004) +0.8 (+0.2 to +1.4)
DBP 24035 83 (0.001) 4.9 (0.001) +0.6 (+0.3 to +0.9)
No.: Number of subjects included in the analysis.
Chi-square. Statistic derived by Fisher’s method with unweighted P-value between parentheses.8
Z-score. Statistic derived by Stouffer’s method with one-sided P-value between parentheses.8 The combined z-scores were weighted
by the number of subjects in each group.
Association size. Increase in the blood pressure (mm Hg) associated with a twofold increase in the blood lead concentration (with 95%
confidence interval between parentheses).
aIncludes also one study55 in which the effects in men and women were not reported separately.
bIncludes Sokas et al75 (99% men).
unless care is taken to ensure this is not occurring.
No significant differences between genders were
observed but there seems a trend that blacks are
more susceptible than whites. Differences in genetic
and socio-economic background might make blacks
more susceptible to the possible rising effects of
blood lead on blood pressure.
The biologic plausibility of a causal relationship
between an increased blood pressure and lead
exposure has been mainly investigated in animal
experiments. The most likely mechanisms include
impairment of renal function,1 interference with the
balance between the renin-angiotensin-aldosterone
axis and the renal kallikrein system,48,66,91 direct
actions at the level of the vascular smooth muscle
cells,92 alternations of the transport of ions across
the cellular membranes,51 potentiation of sympath-
etic stimulation93 and nitric oxide inactivation.94,95
Notwithstanding these biological mechanisms of
actions, in the majority of the population studies,
the association between blood pressure and blood
lead concentration did not reach statistical signifi-
cance. On the other hand epidemiological studies
can only show associations but not prove causation
or lack thereof. On balance across all human studies
the relationship between blood pressure and blood
lead concentration is inconsistent based on the
observation that many studies did not reach the
level of significance. The present meta-analysis
shows an overall statistically significant positive
relationship, which is weak in biological terms.
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